Hong Kong stocks are abnormal | Novartis Jin Hua (09969.HK) is currently up over 4%, with BCL2 inhibitors expected to be included in breakthrough therapies.

According to the Etnet Financial News App, Nuocheng Jienhua (09969.HK) is now up more than 4%, as of the time of writing, it is up 3.87%, at 10.2 Hong Kong dollars, with a turnover of 62.2356 million Hong Kong dollars.